Latest Healthcare in India Stories
MONMOUTH JUNCTION, N.J., Aug. 18, 2011 /PRNewswire/ -- Tris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, has appointed Mr. Dominick DiPaolo to the position of Vice President of Quality, and Mr.
CALGARY, Aug. 11, 2011 /PRNewswire/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC) (NASDAQ: ONCY), will present a corporate overview of the Company at the Wedbush 2011 Life Sciences Management Access Conference on Tuesday, August 16(th), 2011 at 8:35 a.m. ET.
NEW YORK, Aug. 8, 2011 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc.
CALGARY, Aug. 3, 2011 /PRNewswire/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC) (NASDAQ: ONCY), will present a corporate overview of the Company at the 31(st) Canaccord Genuity Growth Conference on Wednesday, August 10(th), 2011 at 3:00 p.m. ET.
Investors seeking a portion of the $8 million available in FY 2012 for the Stateâ€™s popular Biotechnology Investment Incentive Tax Credit submitted more than 180 applications online within three minutes July 1, Maryland Department of Business and Economic Development (DBED) Secretary Christian S.
CALGARY, July 5, 2011 /PRNewswire/ - Oncolytics Biotech Inc. (TSX: ONC) (NASDAQ: ONCY) ("Oncolytics") today announced the appointment of George M. Gill, MD as Chief Medical Officer.
SAN DIEGO, June 13, 2011 /PRNewswire/ -- Millennium Laboratories, a leading provider of medication monitoring services to physicians and staff treating chronic pain, announced today the hiring of Martin Price as General Counsel and Janna Sipes as Senior Vice President, Regulatory Counsel, Chief Compliance Officer. As Millennium Laboratories General Counsel, Mr.
DALLAS, June 9, 2011 /PRNewswire/ -- According to a new market research report, 'Global LED Driver IC Market for Display & Lighting Applications (2010 - 2015)', published by MarketsandMarkets (http://www.marketsandmarkets.com), the total global LED Driver IC market is expected to be worth $4,424.0 million by 2015, out of which the display application accounted for the largest share; i.e.
MALVERN, Pa., June 8, 2011 /PRNewswire/ -- TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule Smac mimetic drugs to treat cancer, today announced the appointment of Mr. Jonathan B.
- One of the side scenes of the stage in a theater, or the space included between the side scenes.
- The outside stock exchange, or “curb market,” of Paris.
- A flute or groove on the blade of a sword.
- A section of stage scenery placed in a wing of a theatre.